Instructions for Grinterol (Ursodeoxycholic acid) 250 mg
Brief description
JSC Grindex, Latvia,
Dissolving of small and medium cholesterol stones in a functioning gallbladder, biliary reflux gastritis, primary biliary cirrhosis of the liver, chronic hepatitis, primary sclerosing cholangitis, cystic fibrosis, non-alcoholic steatohepatitis, alcoholic liver disease, biliary tract dysquinesia;
Composition Grinterol
- One capsule contains:
- active substance:
- ursodeoxycholic acid 250.0 mg;
- auxiliary substances:
- cornstarch 73.0 mg,
- silicon dioxide 5.0 mg,
- magnesium stearate 2.0 mg;
capsule (case and cap):
titanium dioxide (E 171) 2%, gelatin up to 100%.
Description:
Solid gelatine capsules № 0, body and cap in white.
The contents of the powder are white or almost white.
ATC codes Grinterol
A05AA02 Ursodeoxycholic acid
Clinical-pharmacological groups / Group affiliation
A drug Ursodeoxycholic acid that helps dissolve cholesterol gallstones
Hepatoprotector
Active substance Grinterol
ursodeoxycholic acid
Pharmacotherapy group
Hepatoprotective agent
Storage Conditions
The drug Ursodeoxycholic acid should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is four years.
Testimony Grinterol:
- dissolving cholesterol gallbladder stones;
- biliary reflux gastritis;
- primary biliary cirrhosis of the liver in the absence of signs of discompensation;
- chronic hepatitis of different origins;
- primary sclerosing cholangitis;
- cystic fibrosis (as part of complex therapy);
- non-alcoholic steatohepatitis;
- alcoholic liver disease (ABP);
- biliary dyskinesia.
Method of use, course and dosage Ursodeoxycholic acid
For children and adults with a body weight of less than forty-seven kg, ursodeoxycholic acid in the form of a suspension is recommended.
Dissolving cholesterol gallstones
The recommended dose is ten mg/kg body weight per day, which corresponds to:
Use in children Grinterol
Contraindicated: Children's age up to three years (for capsules).
Use with caution in children aged three to four years, as it may be difficult to swallow capsules.
- Nosology Grinterol (ICD codes)
- B18.9
- Chronic viral hepatitis unspecified
- E84
- Cystic fibrosis
- K29.6
- Other gastritis
- K70
- Alcoholic liver disease
- K73
- Chronic hepatitis not classified elsewhere
- K74.3
- Primary biliary cirrhosis
- K76.0
- Fatty liver (liver degeneration) not classified elsewhere
- K80
- Gallstone disease [cholelitiasis] (incl. hepatic colic)
- K82.8
- Other refined diseases of the gallbladder and bubble duct (including dyskinesia)
- K83.0
- Holangit
